Michael Nader to Substance-Related Disorders
This is a "connection" page, showing publications Michael Nader has written about Substance-Related Disorders.
Connection Strength
2.464
-
Nader MA. Animal models for addiction medicine: From vulnerable phenotypes to addicted individuals. Prog Brain Res. 2016; 224:3-24.
Score: 0.482
-
Nader MA, Balster RL, Henningfield JE. William L. Woolverton: a case history in unraveling the behavioral pharmacology of stimulants. Neuropharmacology. 2014 Dec; 87:4-8.
Score: 0.437
-
Gould RW, Porrino LJ, Nader MA. Nonhuman primate models of addiction and PET imaging: dopamine system dysregulation. Curr Top Behav Neurosci. 2012; 11:25-44.
Score: 0.370
-
Nader MA, Czoty PW, Gould RW, Riddick NV. Review. Positron emission tomography imaging studies of dopamine receptors in primate models of addiction. Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12; 363(1507):3223-32.
Score: 0.296
-
Nader MA, Czoty PW. Brain imaging in nonhuman primates: insights into drug addiction. ILAR J. 2008; 49(1):89-102.
Score: 0.281
-
Newman AH, Grundt P, Nader MA. Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents. J Med Chem. 2005 Jun 02; 48(11):3663-79.
Score: 0.235
-
Heilig M, Epstein DH, Nader MA, Shaham Y. Time to connect: bringing social context into addiction neuroscience. Nat Rev Neurosci. 2016 09; 17(9):592-9.
Score: 0.126
-
Keck TM, John WS, Czoty PW, Nader MA, Newman AH. Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis. J Med Chem. 2015 Jul 23; 58(14):5361-80.
Score: 0.116
-
Newman AH, Blaylock BL, Nader MA, Bergman J, Sibley DR, Skolnick P. Medication discovery for addiction: translating the dopamine D3 receptor hypothesis. Biochem Pharmacol. 2012 Oct 01; 84(7):882-90.
Score: 0.096
-
Balster RL, Nader MA, Freeman KB. Obituary: William L. Woolverton. Psychopharmacology (Berl). 2013 Sep; 229(2):379-81.
Score: 0.026